Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Receivables (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Change in Receivables for 7 consecutive years, with $133000.0 as the latest value for Q1 2025.

  • For Q1 2025, Change in Receivables changed N/A year-over-year to $133000.0; the TTM value through Mar 2025 reached $170000.0, changed N/A, while the annual FY2023 figure was -$2.5 million, 251.25% down from the prior year.
  • Change in Receivables hit $133000.0 in Q1 2025 for Bicycle Therapeutics, down from $49.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $49.9 million in Q3 2023 and bottomed at -$49.8 million in Q2 2023.
  • Average Change in Receivables over 4 years is -$477363.6, with a median of -$991000.0 recorded in 2022.
  • On a YoY basis, Change in Receivables climbed as much as 614.5% in 2023 and fell as far as 582.14% in 2023.
  • Bicycle Therapeutics' Change in Receivables stood at $1.0 million in 2021, then skyrocketed by 98.7% to $2.0 million in 2022, then soared by 2407.59% to $49.9 million in 2023, then crashed by 99.73% to $133000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $133000.0, $49.9 million, and -$49.8 million for Q1 2025, Q3 2023, and Q2 2023 respectively.